ALNYLAM PHARMACEUTICALS, INC.;ALNYLAM PHARMACEUTICALS; INC.;ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
发明人:
BRIAN BETTENCOURT,KEVIN FITZGERALD,MAKIKO YASUDA,ROBERT J. DESNICK,WILLIAM QUERBES
申请号：
BR112016007226
公开号：
BR112016007226A2
申请日:
2014.10.03
申请国别(地区):
BR
年份:
2017
代理人:
摘要：
The invention relates to double-stranded ribonucleic acid (dsrna) compositions directed to the alas1 gene, and methods of using such dsrna compositions to alter (e.g., inhibit) expression of alas1.a invenção se relaciona com composições de ácido ribonucleico de fita dupla (dsrna) se dirigindo ao gene alas1, e métodos de uso de tais composições de dsrna para alterar (p.ex., inibir) a expressão de alas1.
